Daniel Salas‐Lloret

Statistics

Publications

Citations

114

H-Index

Active since

2019

Affiliations

Leiden University Medical Center(Current)

Universidad de Sevilla

Centro Andaluz de Biología Molecular y Medicina Regenerativa

Universidad Pablo de Olavide

Junta de Andalucía

Daniel Salas‐Lloret is an author at Leiden University Medical Center specializing in molecular biology, substrate binding specificity, and e3 ubiquitin ligase substrate recognition.

ORCID

Publications per year

2019–2024

Publications

TULIP2: An Improved Method for the Identification of Ubiquitin E3-Specific Targets

Daniel Salas‐Lloret, Giulia Agabitini, Román González‐Prieto · Frontiers in Chemistry · 2019 · 27 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

SUMO-activated target traps (SATTs) enable the identification of a comprehensive E3-specific SUMO proteome

Daniel Salas‐Lloret, Nicolette S. Jansen, Easa Nagamalleswari et al. · Science Advances · 2023 · 22 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

RNF212B E3 ligase is essential for crossover designation and maturation during male and female meiosis in the mouse

Yazmine B. Condezo, Raquel Sainz-Urruela, Laura Gómez-H et al. · Proceedings of the National Academy of Sciences · 2024 · 22 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis

Daniel Salas‐Lloret, Néstor García‐Rodríguez, Emily Soto-Hidalgo et al. · Nature Communications · 2024 · 18 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype

Nadia Cobo‐Vuilleumier, Silvia Rodríguez-Fernández, Livia López–Noriega et al. · Clinical and Translational Medicine · 2024 · 13 citations · Full text

Life Sciences, Immunology, Pharmacology +13

1–5 of 6